Anixa Biosciences Inc

ANIX

Anixa Biosciences Inc

ANIX

Insider Sentiment (TTM):

Last Purchase:2026-06-16Last Sale:2023-07-31Shares Purchased (TTM):48,836Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:4,994,707Shares Outstanding:33,593,000Institutional Ownership Pct.:14.87%

Earnings Market Reaction:

Filing Date:2026-06-10Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	1	2	1	1	2	1	1	1	1	1	1	3
Short Term Investments	12	13	14	15	14	16	19	20	22	23	23	22
Receivables Net Current	0	-	-	-	-	-	0	0	0	0	0	0
Prepaid Expense And Other Assets Current	1	1	1	1	1	1	1	2	1	1	1	1
Assets Current	15	15	16	17	17	19	21	23	24	25	25	26
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Assets	15	15	16	18	17	19	22	23	24	25	26	27
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	0	0	0	0	0	1	1	0	0	0	0	0
Accrued Liabilities Current	1	1	2	2	2	1	2	2	1	1	2	2
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	2	1	2	2	2	2	3	2	2	2	2	2
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities	2	1	2	2	2	2	3	2	2	2	2	2
Stockholders Equity Inclu…
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	271	269	267	265	262	261	260	259	258	256	252	251
Retained Earnings Accumulated Deficit	-257	-254	-252	-249	-247	-244	-241	-238	-235	-231	-228	-226
Treasury Stock Value	-	-	-	-	-	-0	-0	-	-	-	-	-
Stockholders Equity	13	15	15	15	15	18	20	22	23	24	24	26
Minority Interest	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1
Liabilities And Stockholders Equity	15	15	16	18	17	19	22	23	24	25	26	27
Preferred Stock Par Or Stated Value Per Share	100	100	100	100	100	100	100	100	100	100	100	100
Preferred Stock Shares Authorized	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	34	33	33	33	32	32	32	32	32	32	31	31
Shares Outstanding	34	33	33	33	32	32	32	32	32	32	31	31
Treasury Stock Common Shares	-	0	0	0	0	0	0	-	-	-	0	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-14.43%	5.37%	-9.40%	39.15%	-	-	-	-	-	-	-	-
2025	-4.89%	4.51%	-3.38%	33.07%	35.43%	16.93%	8.28%	36.75%	51.99%	-6.33%	-9.81%	-19.30%
2024	3.90%	-4.55%	-21.10%	-13.33%	19.61%	24.71%	-0.62%	1.25%	-0.31%	28.89%	40.00%	32.00%
2023	-	-	-	-8.90%	15.03%	11.66%	-7.37%	-13.88%	-16.15%	-10.16%	-35.26%	-36.25%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31
Liquidity Ratios
Current Ratio	9.79	12.18	8.08	8.45	8.89	9.35	8.54	11.31	14.40	15.19	12.50	14.22
Quick Ratio	9.16	11.49	7.71	7.76	8.27	8.63	8.04	10.56	13.95	14.57	11.89	13.93
Working Capital	13.19M	13.81M	13.92M	15.38M	14.88M	16.69M	18.86M	20.67M	22.53M	23.56M	23.33M	24.54M
Leverage & Debt
Debt to Equity	0.12	0.09	0.15	0.15	0.14	0.12	0.14	0.10	0.08	0.07	0.09	0.08
Debt Ratio	0.11	0.09	0.13	0.13	0.12	0.12	0.13	0.10	0.07	0.07	0.08	0.07
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01
Days Sales Outstanding TTM	-	-	-	-	-	-	-	-	-	467.55	274.62	580.52
Receivables Turnover TTM	0.00	-	-	-	-	-	0.00	0.00	0.00	0.78	1.33	0.63
Per Share Metrics
Diluted EPS TTM	-0.30	-0.31	-0.34	-0.34	-0.38	-0.39	-0.40	-0.39	-0.37	-0.34	-0.32	-0.34
Free Cash Flow Per Share TTM	-0.21	-0.21	-0.22	-0.21	-0.25	-0.25	-0.23	-0.26	-0.22	-0.21	-0.20	-0.19
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-	-	-	-	-	-	-	-	-5,744.76%	-5,243.33%	-5,509.05%
Net Profit Margin TTM	-	-	-	-	-	-	-	-	-	-5,132.86%	-4,671.90%	-5,005.24%
Growth Metrics
Net Revenue Growth (1Y)	-	-	-	-	-	-100.00%	-100.00%	-100.00%	-100.00%	-	-	-140.86%
Net Income Growth (1Y)	-18.11%	-18.14%	-13.95%	-10.03%	4.75%	16.82%	29.43%	18.33%	8.69%	-10.46%	-27.83%	-26.88%
EPS Growth (1Y)	-21.50%	-20.71%	-15.42%	-11.20%	3.81%	14.09%	25.70%	14.35%	5.34%	-11.95%	-29.25%	-28.11%
Valuation Metrics
P/E TTM	-10.07	-9.80	-12.27	-8.88	-7.35	-7.42	-8.79	-8.56	-8.12	-13.24	-9.98	-10.58
P/B TTM	7.62	6.70	9.61	6.45	6.03	5.23	5.91	4.89	4.20	6.05	4.19	4.36
P/S TTM	-	-	-	-	-	-	-	-	-	679.83	466.18	529.51
Market Cap	100.78M	101.05M	134.04M	99.38M	89.84M	93.37M	111.64M	106.42M	94.78M	142.76M	97.90M	111.20M
Enterprise Value	99.30M	99.50M	132.79M	97.88M	87.93M	92.32M	110.37M	105.19M	93.79M	141.77M	96.98M	108.00M
Calculated Values
Free Cash Flow TTM	-7.12M	-6.88M	-7.17M	-6.85M	-7.98M	-7.93M	-7.34M	-8.38M	-7.18M	-6.53M	-6.21M	-5.83M
Net Debt	-1.48M	-1.55M	-1.24M	-1.50M	-1.91M	-1.05M	-1.27M	-1.23M	-995.00K	-998.00K	-915.00K	-3.20M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-16Purchase

Owner: Titterton, Lewis H Jr

Title: -

Shares: 2,836

Price/Share: $2.64

Value: $7,487.04

Shares Owned: 972,170

Relationship: Director

Ownership: Direct

2026-06-12Purchase

Owner: Kumar, Amit

Title: Chief Executive Officer

Shares: 21,000

Price/Share: $2.50

Value: $52,500.00

Shares Owned: 630,812

Relationship: Director,Officer

Ownership: Direct

2026-01-28Purchase

Owner: Baskies, Arnold M

Title: -

Shares: 10,000

Price/Share: $3.04

Value: $30,400.00

Shares Owned: 135,000

Relationship: Director

Ownership: Direct

2025-07-31Purchase

Owner: Titterton, Lewis H Jr

Title: -

Shares: 10,000

Price/Share: $3.08

Value: $30,800.00

Shares Owned: 953,334

Relationship: Director

Ownership: Direct

2025-07-30Purchase

Owner: Kumar, Amit

Title: Chief Executive Officer

Shares: 5,000

Price/Share: $3.16

Value: $15,800.00

Shares Owned: 579,925

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-16	Titterton, Lewis H Jr	Director	-	Direct	Purchase	2,836	2.64	$7,487.04	972,170	4
2026-06-12	Kumar, Amit	Director,Officer	Chief Executive Officer	Direct	Purchase	21,000	2.50	$52,500.00	630,812	4
2026-01-28	Baskies, Arnold M	Director	-	Direct	Purchase	10,000	3.04	$30,400.00	135,000	4
2025-07-31	Titterton, Lewis H Jr	Director	-	Direct	Purchase	10,000	3.08	$30,800.00	953,334	4
2025-07-30	Kumar, Amit	Officer	Chief Executive Officer	Direct	Purchase	5,000	3.16	$15,800.00	579,925	4
2025-07-18	Baskies, Arnold M	Director	-	Direct	Purchase	5,000	3.39	$16,950.00	125,000	4
2025-07-11	Titterton, Lewis H Jr	Director	-	Direct	Purchase	10,000	3.14	$31,400.00	943,334	4
2025-07-11	Kumar, Amit	Officer	Chief Executive Officer	Direct	Purchase	5,000	3.15	$15,750.00	574,925	4
2025-06-04	Kumar, Amit	Officer	Chief Executive Officer	Direct	Purchase	10,000	2.85	$28,500.00	569,925	4
2025-01-28	Baskies, Arnold M	Director	-	Direct	Purchase	5,000	2.82	$14,100.00	120,000	4
2025-01-24	Titterton, Lewis H Jr	Director	-	Direct	Purchase	1,000	3.00	$3,000.00	933,334	4
2025-01-22	Titterton, Lewis H Jr	Director	-	Direct	Purchase	2,000	3.01	$6,020.00	930,334	4
2025-01-21	Titterton, Lewis H Jr	Director	-	Direct	Purchase	6,000	2.59	$15,540.00	928,334	4
2025-01-17	Titterton, Lewis H Jr	Director	-	Direct	Purchase	10,000	2.57	$25,700.00	922,334	4
2025-01-15	Kumar, Amit	Officer	Chief Executive Officer	Direct	Purchase	43,000	2.23	$95,890.00	559,925	4
2025-01-15	Catelani, Michael	Officer	President, COO, & CFO	Direct	Purchase	9,289	2.15	$19,971.35	44,500	4
2024-07-31	Titterton, Lewis H Jr	Director	-	Direct	Purchase	5,580	3.23	$18,023.40	896,334	4
2024-07-26	Baskies, Arnold M	Director	-	Direct	Purchase	5,000	3.09	$15,450.00	115,000	4
2024-07-26	Titterton, Lewis H Jr	Director	-	Direct	Purchase	7,700	3.03	$23,331.00	869,108	4
2024-06-14	Titterton, Lewis H Jr	Director	-	Direct	Purchase	4,000	2.68	$10,720.00	860,612	4
2024-06-13	Titterton, Lewis H Jr	Director	-	Direct	Purchase	405	2.70	$1,093.50	856,612	4
2024-06-11	Titterton, Lewis H Jr	Director	-	Direct	Purchase	7,102	2.66	$18,891.32	856,207	4
2024-06-07	Kumar, Amit	Officer	Chief Executive Officer	Direct	Purchase	25,000	2.41	$60,250.00	516,925	4
2024-06-07	Catelani, Michael	Officer	President, COO, & CFO	Direct	Purchase	6,250	2.40	$15,000.00	35,211	4
2024-06-07	Titterton, Lewis H Jr	Director	-	Direct	Purchase	10,738	2.52	$27,059.76	848,775	4
2024-04-09	Titterton, Lewis H Jr	Director	-	Direct	Purchase	15,009	3.28	$49,229.52	838,037	4
2024-03-15	Baskies, Arnold M	Director	-	Direct	Purchase	10,000	3.63	$36,300.00	110,000	4
2024-03-15	Kumar, Amit	Officer	Chief Executive Officer	Direct	Purchase	30,000	3.22	$96,600.00	491,925	4
2023-07-31	Kumar, Amit	Director,Officer	Chief Executive Officer	Direct	Sale	11,800	3.57	$42,126.00	461,925	4
2023-07-20	Catelani, Michael	Officer	President, COO & CFO	Direct	Purchase	5,500	3.64	$20,020.00	26,655	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

14.87%

Inst. Shares: 4,994,707

Shares Outstanding: 33,593,000

2025-12-31

16.45%

Inst. Shares: 5,467,506

Shares Outstanding: 33,240,000

2025-09-30

16.39%

Inst. Shares: 5,318,277

Shares Outstanding: 32,454,000

2025-06-30

16.23%

Inst. Shares: 5,270,793

Shares Outstanding: 32,476,000

2025-03-31

17.13%

Inst. Shares: 5,514,664

Shares Outstanding: 32,202,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	4,994,707	33,593,000	14.87%
2025-12-31	5,467,506	33,240,000	16.45%
2025-09-30	5,318,277	32,454,000	16.39%
2025-06-30	5,270,793	32,476,000	16.23%
2025-03-31	5,514,664	32,202,000	17.13%
2024-12-31	5,842,381	32,197,000	18.15%
2024-09-30	5,544,225	31,898,000	17.38%
2024-06-30	5,510,376	32,054,000	17.19%
2024-03-31	5,093,382	31,914,000	15.96%
2023-12-31	4,341,950	31,446,000	13.81%
2023-09-30	3,850,605	30,980,000	12.43%
2023-06-30	3,511,556	30,974,000	11.34%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Anixa Biosciences Inc (ANIX) — SEC Financial Statements & Analysis

Anixa Biosciences Inc (ANIX) is a pharmaceutical preparations company, incorporated in DE. Anixa Biosciences Inc trades on Nasdaq as: ANIX. Based on its latest SEC filing (Form 10-Q, period ending 2026-04-30), Anixa Biosciences Inc reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.12x, a Price-to-Sales (P/S) ratio of 679.83x (TTM), a Price-to-Book (P/B) ratio of 7.62 (TTM), at a market cap of $100.78M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 0.12x
P/S TTM: 679.83x
P/B TTM: 7.62
Market Cap: $100.78M

Data as of 2026-04-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Anixa Biosciences Inc in?

Anixa Biosciences Inc (ANIX) operates in the Pharmaceutical Preparations industry.

What is ANIX's market cap?

Anixa Biosciences Inc (ANIX) has a market capitalization of $100.78M as of 2026-04-30.

What exchange does ANIX trade on?

Anixa Biosciences Inc (ANIX) trades on the Nasdaq.

Where is Anixa Biosciences Inc incorporated?

Anixa Biosciences Inc is incorporated in DE.

Anixa Biosciences Inc (ANIX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.